Evaluating an hepatic enzyme induction mechanism through coarse- and fine-grained measurements of an in silico liver

  • Authors:
  • Glen E. P. Ropella;Sunwoo Park;C. Anthony Hunt

  • Affiliations:
  • Tempus Dictum, Inc., Portland, Oregon 97214-5328;Department of Bioengineering and Therapeutic Sciences, The University of California, San Francisco, California 94143-0446;Department of Bioengineering and Therapeutic Sciences, The University of California, San Francisco, California 94143-0446

  • Venue:
  • Complexity
  • Year:
  • 2009

Quantified Score

Hi-index 0.00

Visualization

Abstract

Results from simulation experiments falsified the hypothesis that a uniform distribution of simulated drug passing through an in silico liver (ISL) will produce a uniform extent of enzyme induction (EI). Wet-lab EI experiments, as formulated, are infeasible. The simulated EI is intended to have a hepatic counterpart. The ISL is synthetic, physiologically based, fine-grained, and multi-agent. It has been validated against in situ drug disposition data. We discuss methodological considerations regarding the phenomenal manifold, multi-level observation, and manipulation of synthetic models and their referents. Interestingly, a lower probability of metabolism caused higher EI and, counter-intuitively, more extraction. © 2008 Wiley Periodicals, Inc. Complexity, 2009 This article was submitted as an invited paper resulting from the “Understanding Complex Systems” conference held at the University of Illinois at Urbana-Champaign, May 2007.